High and low efficiency neutralization epitopes on the haemagglutinin of type A influenza virus

Journal of General Virology

Volumn 78, Issue 10, 1997, Pages 2441-2446

  Schofield, D J ^a,c   Stephenson, J R ^b   Dimmock, N J ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; VIRUS ANTIBODY; VIRUS HEMAGGLUTININ;

ANTIBODY AFFINITY; ARTICLE; BINDING AFFINITY; BINDING KINETICS; CHEMICAL REACTION KINETICS; CONTROLLED STUDY; INFLUENZA VIRUS A; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS NEUTRALIZATION;

INFLUENZA VIRUS; INFLUENZAVIRUS A;

EID: 0030815421     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-78-10-2441     Document Type: Article

References (40)

1. Armstrong, S. J. & Dimmock, N. J. (1992). Neutralization of influenza virus by low concentrations of HA-specific polymeric IgA inhibits viral fusion activity but activation of the ribonucleoprotein is also inhibited. Journal of Virology 66, 3823-3832.
2. Askonas, B. A., Taylor, P. M. & Esquivel, F. (1988). Cytotoxic T cells in influenza infection. Annals of the New York Academy of Sciences 532, 230-237.
3. Barbas, III, C. F., Hu, D., Dunlop, N., Sawyer, L., Cababa, D., Hendry, R. M., Nara, P. L. & Burton, D. R. (1994). In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type I to enhance affinity and broaden strain specificity. Proceedings of the National Academy of Sciences, USA 91, 3809-3813.
4. Brown, L. E., Murray, J. M., White, D. O. & Jackson, D. C. (1990). An analysis of the properties of monoclonal antibodies directed to epitopes on influenza virus hemagglutinin. Archives of Virology 114, 1-26.
5. Burton, D. R., Pyati, J., Koduri, R., Sharp, S. J., Thornton, G. B., Parren, P. W. H. I., Sawyer, L. S. W., Hendry, R. M., Dunlop, N., Nara, P. L., Lamacchia, M., Garratty, E., Stiehm, E. R., Bryson, Y., Cao, Y., Moore, J. P., Ho, D. D. & Barbas, III, C. F. (1994). Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266, 1024-1027.
6. Conley, A. J., Gorny, M. K., Kessler, J. A., Boots, L. J., Ossorio-Castro, M., Koenig, S., Lineberger, D. W., Emini, E., Williams, C. & Zolla-Pazner, S. (1994). Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 antibody, 447-52D. Journal of Virology 68, 6994-7000.
7. Dimmock, N. J. (1993). Neutralization of animal viruses. Current Topics in Microbiology and Immunology 183, 1-149.
8. Dimmock, N. J. (1995). Update on the neutralization of animal viruses. Reviews in Medical Virology 5, 165-179.
9. Ditzel, H. J., Binley, J. M., Moore, J. P., Sodroski, J., Sullivan, N., Sawyer, L. S. W., Hendry, R. M., Yang, W.-P., Barbas, III, C. F. & Burton, D. R. (1995). Neutralizing recombinant human antibodies to a conformational V2-and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated using an epitope masking procedure. Journal of Immunology 154, 895-908.
10. Dulbecco, R., Vogt, M. & Strickland, A. G. R. (1956). A study of the basic aspects of neutralization of two animal viruses, Western equine encephalitis virus and poliomyelitis virus. Virology 2, 162-205.
11. Ey, P. L., Prowse, S. J. & Jenkin, C. R. (1978). Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-Sepharose. Immunochemistry 15, 429-436.
12. Fazekas de St Groth, S. & Webster, R. G. (1963). The neutralization of animal viruses. IV. Parameters of the influenza virus-antibody system. Journal of Immunology 90, 151-164.
13. Frankel, M. E. & Gerhard, W. (1979). The rapid determination of binding constants for antiviral antibodies by a radioimmunoassay. An analysis of the interaction between hybridoma proteins and influenza virus. Molecular Immunology 16, 101-106.
14. Friguet, B., Chaffotte, A. F., Djavadi-Ohaniance, L. & Goldberg, M. E. (1985). Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. Journal of Immunological Methods 77, 305-319.
15. Icenogle, J. C., Shiwen, H., Duke, G., Gilbert, S., Rueckert, R. & Anderegg, J. (1983). Neutralization of poliovirus by a monoclonal antibody: kinetics and stoichiometry. Virology 127, 412-425.
16. Kelly, D. C. & Dimmock, N. J. (1974). Fowl plague virus replication in mammalian cell-erythocyte heterokaryons : studies concerning the actinomycin D and ultra-violet sensitive phase in influenza virus replication. Virology 61, 210-222.
17. Kilbourne, E. D. (1987). Influenza. New York: Plenum Medical Book Co.
18. McInerney, T. L., McLain, L., Armstrong, & Dimmock, N. J. (1997). A human IgG1 (b12) specific for the CD4 binding site of HIV-1 neutralizes by inhibiting the virus fusion entry process, but b12 Fab neutralizes by inhibiting a post-fusion event. Virology 233, 313-326.
19. McLain, L. & Dimmock, N. J. (1994). Single-and multi-hit kinetics of immunoglobulin G neutralization of human immunodeficiency virus type 1 by monoclonal antibodies. Journal of General Virology 75, 1457-1460.
20. Moore, J. P., Sattentau, Q. J., Wyatt, R. & Sodroski, J. (1994). Mapping the topology of the human immunodeficiency virus glycoprotein gp120 with a panel of monoclonal antibodies. Journal of Virology 68, 469-484.
21. Moore, J. P., Cao, Y., Quing, L., Sattentau, Q. J., Pyati, J., Koduri, R., Robinson, J., Barbas, III, C. F., Burton, D. R. & Ho, D. D. (1995). Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. Journal of Virology 69, 101-109.
22. Nakamura, G. R., Byrn, R., Wilkes, D. M., Fox, J. A., Hobbs, H. R., Hastings, M. C., Norcross, M. A., Fendly, B. M. & Berman, P. W. (1993). Strain specificity and binding affinity requirements of neutralizing antibodies to the C4 domain of gp120 from human immunodeficiency virus type 1. Journal of Virology 67, 6179-6191.
23. Outlaw, M. C. & Dimmock, N. J. (1991). Insights into neutralization of animal viruses gained from the study of influenza viruses. Epidemiology and Infection 106, 205-220.
24. Outlaw, M. C. & Dimmock, N. J. (1993). IgG-neutralization of type A influenza viruses and the inhibition of the endosomal fusion stage of the infectious pathway. Virology 195, 413-421.
25. Outlaw, M. C., Armstrong, S. J. & Dimmock, N. J. (1990). Mechanisms of neutralization of influenza virus vary according to IgG concentration. Virology 178, 478-485.
26. Parren, P. W. H. I., Ditzel, H. J., Gulizia, R. J., Barbas, III, C. F., Burton, D. R. & Mosier, D. E. (1995). Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing monoclonal antibody against the gp120 CD4 binding site. AIDS 9, F1-6.
27. Potter, C. W. (1994). Attenuated influenza virus vaccines. Reviews in Medical Virology 4, 279-292.
28. Rigg, R. J., Carver, A. S. & Dimmock, N. J. (1989). IgG-neutralized influenza virus undergoes primary, but not secondary uncoating in vivo. Journal of General Virology 70, 2097-2109.
29. Roben, P., Moore, J. P., Sodroski, J., Barbas, III, C. F. & Burton, D. R. (1994). Recognition of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1. Journal of Virology 68, 4821-4828.
30. Sattentau, Q. J. & Moore, J. P. (1995). Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer. Journal of Experimental Medicine 182, 185-196.
31. Schofield, D. J. & Dimmock, N. J. (1996). Determination of affinities of a panel of IgGs and Fabs for an enveloped (influenza A) virus using surface plasmon resonance. Journal of Virological Methods 62, 33-42.
32. Stamatatos, L. & Cheng-Mayer, C. (1995). (1) Structural modifications of the envelope of gp120 glycoprotein of human immunodeficiency virus type 1 upon oligomerization and (2) differential V3 loop epitope exposure of isolates displaying distinct tropism upon virion-soluble receptor binding. Journal of Virology 69, 6191-6198.
33. Stevens, F. J. (1987). Modification of an ELISA-based procedure for affinity determination: correction necessary for use with bivalent antibody. Molecular Immunology 24, 1055-1060.
34. Sugrue, R. J., Bahadur, G., Zambon, M. C., Hall-Smith, M., Douglas, A. R. & Hay, A. J. (1990). Specific structural alteration of the influenza haemagglutinin by amantadine. EMBO Journal 9, 3469-3476.
35. Taylor, H. P., Armstrong, S. J. & Dimmock, N. J. (1987). Quantitative relationships between an influenza virus and neutralizing antibody. Virology 159, 288-298.
36. Ueki, Y., Goldfarb, I. S., Harindranath, N., Gore, M., Koprowski, H., Notkins, A. L. & Casali, P. (1990). Clonal analysis of a human antibody response: quantitation of precursors of antibody-producing cells and generation and characterization of monoclonal IgM, IgG and IgA to rabies virus. Journal of Experimental Medicine 171, 19-34.
37. VanCott, T. C., Bethke, F. R., Polonis, V. R., Gorny, M. K., Zolla-Pazner, S., Redfield, R. R. & Birx, D. L. (1994). Dissociation rate of antibody-gp120 binding interactions is predictive of V3-mediated neutralization of HIV-1. Journal of Immunology 153, 449-459.
38. Webster, R. G., Bean, W. J., Gorman, O. T., Chambers, T. M. & Kawaoka, Y. (1992). Evolution and ecology of influenza A viruses. Microbiological Reviews 56, 152-179.
39. Wells, M. A., Albrecht, P. & Ennis, F. A. (1981). Recovery from a viral respiratory tract infection. I Influenza pneumonia in normal and T cell-deficient mice. Journal of Immunology 126, 1036-1041.
40. Wiley, D. C., Wilson, I. A. & Skehel, J. J. (1981). Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289, 373-378.